Beatriz M. Carreno

20.3k total citations · 4 hit papers
75 papers, 11.3k citations indexed

About

Beatriz M. Carreno is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Beatriz M. Carreno has authored 75 papers receiving a total of 11.3k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Immunology, 32 papers in Oncology and 23 papers in Molecular Biology. Recurrent topics in Beatriz M. Carreno's work include T-cell and B-cell Immunology (41 papers), Immunotherapy and Immune Responses (38 papers) and Immune Cell Function and Interaction (34 papers). Beatriz M. Carreno is often cited by papers focused on T-cell and B-cell Immunology (41 papers), Immunotherapy and Immune Responses (38 papers) and Immune Cell Function and Interaction (34 papers). Beatriz M. Carreno collaborates with scholars based in United States, Canada and Hungary. Beatriz M. Carreno's co-authors include Mary Collins, Vincent Ling, Laura Carter, Lori Fitz, Lynette A. Fouser, Tasuku Honjo, Clive R. Wood, Yoshiko Iwai, Hiroyuki Nishimura and Michael C. Byrne and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Beatriz M. Carreno

73 papers receiving 11.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Engagement of the Pd-1 Immunoinhibitory Receptor by a Novel B7 Family Member Leads to Negative Regulation of Lymphocyte Activation

2000 4.2k citations Andrew J. Long, Yoshiko Iwai et al. The Journal of Experimental Medicine profile →
A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells

2015 997 citations Beatriz M. Carreno, Vincent Magrini et al. Science profile →
The B7 Family of Ligands and Its Receptors: New Pathways for Costimulation and Inhibition of Immune Responses

2002 728 citations Beatriz M. Carreno, Mary Collins profile →
PD-1:PD-L inhibitory pathway affects both CD4+ and CD8+ T cells and is overcome by IL-2

2002 548 citations Laura Carter, Lynette A. Fouser et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Beatriz M. Carreno United States	40	8.4k	5.6k	2.1k	796	661	75	11.3k
Gefeng Zhu United States	34	9.1k 1.1×	8.5k 1.5×	2.0k 1.0×	1.1k 1.4×	512 0.8×	44	13.3k
Yoshiko Iwai Japan	21	6.8k 0.8×	7.1k 1.3×	1.8k 0.8×	1.2k 1.5×	436 0.7×	30	10.7k
Dallas B. Flies United States	38	10.6k 1.3×	9.4k 1.7×	2.3k 1.1×	1.3k 1.7×	614 0.9×	65	14.9k
Clive R. Wood United States	21	5.2k 0.6×	4.4k 0.8×	1.8k 0.9×	695 0.9×	663 1.0×	35	8.4k
Scott E. Strome United States	48	6.1k 0.7×	6.9k 1.2×	2.1k 1.0×	1.5k 1.9×	746 1.1×	144	11.5k
Hisaya Akiba Japan	53	8.3k 1.0×	3.4k 0.6×	2.0k 1.0×	347 0.4×	393 0.6×	126	10.8k
Frédéric Triebel France	54	7.0k 0.8×	5.2k 0.9×	1.1k 0.5×	715 0.9×	679 1.0×	167	9.2k
Peter Brossart Germany	62	6.6k 0.8×	4.5k 0.8×	4.9k 2.4×	1.0k 1.3×	858 1.3×	289	12.3k
Christoph Huber Germany	45	5.0k 0.6×	3.5k 0.6×	3.3k 1.6×	462 0.6×	569 0.9×	155	8.6k
Michael R. Verneris United States	54	6.5k 0.8×	4.1k 0.7×	1.5k 0.7×	391 0.5×	382 0.6×	254	10.7k

Countries citing papers authored by Beatriz M. Carreno

Since Specialization

Citations

This map shows the geographic impact of Beatriz M. Carreno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beatriz M. Carreno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beatriz M. Carreno more than expected).

Fields of papers citing papers by Beatriz M. Carreno

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beatriz M. Carreno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beatriz M. Carreno. The network helps show where Beatriz M. Carreno may publish in the future.

Co-authorship network of co-authors of Beatriz M. Carreno

This figure shows the co-authorship network connecting the top 25 collaborators of Beatriz M. Carreno. A scholar is included among the top collaborators of Beatriz M. Carreno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beatriz M. Carreno. Beatriz M. Carreno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Linette, Gerald P., Adham S. Bear, & Beatriz M. Carreno. (2024). Facts and Hopes in Immunotherapy Strategies Targeting Antigens Derived from KRAS Mutations. Clinical Cancer Research. 30(10). 2017–2024. 6 indexed citations

Sharma, Nitika, Estela Noguera-Ortega, Maria Liousia, et al.. (2023). A genetically encoded protein tag for control and quantitative imaging of CAR T cell therapy. Molecular Therapy. 31(12). 3564–3578. 7 indexed citations

Bear, Adham S., Tatiana Blanchard, Michael Ford, et al.. (2021). Biochemical and functional characterization of mutant KRAS epitopes validates this oncoprotein for immunological targeting. Nature Communications. 12(1). 4365–4365. 73 indexed citations

Hundal, Jasreet, Beatriz M. Carreno, Allegra A. Petti, et al.. (2016). pVAC-Seq: A genome-guided in silico approach to identifying tumor neoantigens. Genome Medicine. 8(1). 11–11. 267 indexed citations

Carreno, Beatriz M., Vincent Magrini, Michelle Becker‐Hapak, et al.. (2015). A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells. Science. 348(6236). 803–808. 997 indexed citations breakdown →

Carreno, Beatriz M., Michelle Becker‐Hapak, Alexander C. Huang, et al.. (2013). IL-12p70–producing patient DC vaccine elicits Tc1-polarized immunity. Journal of Clinical Investigation. 123(8). 3383–3394. 135 indexed citations

Kreisel, Daniel, Andrew E. Gelman, Ryuji Higashikubo, et al.. (2012). Strain-Specific Variation in Murine Natural Killer Gene Complex Contributes to Differences in Immunosurveillance for Urethane-Induced Lung Cancer. Cancer Research. 72(17). 4311–4317. 22 indexed citations

Li, Lijin, Peter S. Goedegebuure, Elaine R. Mardis, et al.. (2011). Cancer Genome Sequencing and Its Implications for Personalized Cancer Vaccines. Cancers. 3(4). 4191–4211. 22 indexed citations

Wright, Jill F., Frann Bennett, Jonathan Brooks, et al.. (2008). The Human IL-17F/IL-17A Heterodimeric Cytokine Signals through the IL-17RA/IL-17RC Receptor Complex. The Journal of Immunology. 181(4). 2799–2805. 238 indexed citations

10.

McAllister, Florencia, Adam C. Henry, James L. Kreindler, et al.. (2005). Role of IL-17A, IL-17F, and the IL-17 Receptor in Regulating Growth-Related Oncogene-α and Granulocyte Colony-Stimulating Factor in Bronchial Epithelium: Implications for Airway Inflammation in Cystic Fibrosis. The Journal of Immunology. 175(1). 404–412. 330 indexed citations

11.

Collins, Mary, Vincent Ling, & Beatriz M. Carreno. (2005). The B7 family of immune-regulatory ligands.. Genome Biology. 6(6). 223–223. 258 indexed citations

12.

Madrenas, Joaquı́n, Luan A. Chau, Wendy A. Teft, et al.. (2004). Conversion of CTLA-4 from Inhibitor to Activator of T Cells with a Bispecific Tandem Single-Chain Fv Ligand. The Journal of Immunology. 172(10). 5948–5956. 26 indexed citations

13.

Stephens, Geoffrey L., Rebecca S. McHugh, Matthew J. Whitters, et al.. (2004). Engagement of Glucocorticoid-Induced TNFR Family-Related Receptor on Effector T Cells by its Ligand Mediates Resistance to Suppression by CD4+CD25+ T Cells. The Journal of Immunology. 173(8). 5008–5020. 393 indexed citations

14.

Blazar, Bruce R., Beatriz M. Carreno, Angela Panoskaltsis‐Mortari, et al.. (2003). Blockade of Programmed Death-1 Engagement Accelerates Graft-Versus-Host Disease Lethality by an IFN-γ-Dependent Mechanism. The Journal of Immunology. 171(3). 1272–1277. 267 indexed citations

15.

Carreno, Beatriz M. & Mary Collins. (2003). BTLA: a new inhibitory receptor with a B7-like ligand. Trends in Immunology. 24(10). 524–527. 77 indexed citations

16.

Carter, Laura & Beatriz M. Carreno. (2003). Cytotoxic T-Lymphocyte Antigen-4 and Programmed Death-1 Function as Negative Regulators of Lymphocyte Activation. Immunologic Research. 28(1). 49–60. 28 indexed citations

17.

Baroja, Miren L., Lalitha Vijayakrishnan, Estelle Bettelli, et al.. (2002). Inhibition of CTLA-4 Function by the Regulatory Subunit of Serine/Threonine Phosphatase 2A. The Journal of Immunology. 168(10). 5070–5078. 76 indexed citations

18.

Long, Andrew J., Yoshiko Iwai, Tatyana Chernova, et al.. (2000). Engagement of the Pd-1 Immunoinhibitory Receptor by a Novel B7 Family Member Leads to Negative Regulation of Lymphocyte Activation. The Journal of Experimental Medicine. 192(7). 1027–1034. 4158 indexed citations breakdown →

19.

Carreno, Beatriz M., Frann Bennett, Thu Chau, et al.. (2000). CTLA-4 (CD152) Can Inhibit T Cell Activation by Two Different Mechanisms Depending on Its Level of Cell Surface Expression. The Journal of Immunology. 165(3). 1352–1356. 216 indexed citations

20.

Carreno, Beatriz M., Kathy L. Schreiber, D J McKean, Iwona Stroynowski, & Ted H. Hansen. (1995). Aglycosylated and phosphatidylinositol-anchored MHC class I molecules are associated with calnexin. Evidence implicating the class I-connecting peptide segment in calnexin association.. The Journal of Immunology. 154(10). 5173–5180. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact